Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: Evidence for a hypothalamic site for concurrent development of leptin resistance

Journal of Neuroendocrinology

Volumn 10, Issue 1, 1998, Pages 43-49

  Kalra, P S ^a   Dube, M G ^a   Xu, B ^a   Farmerie, W G ^a   Kalra, S P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Hyperphagia; Hypothalamus; Leptin resistance; NPY receptors

Indexed keywords

COLCHICINE; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENERGY BALANCE; FOOD INTAKE; HYPERPHAGIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS VENTRAL NUCLEUS; WEIGHT GAIN;

ANIMALS; COLCHICINE; DRUG RESISTANCE; EATING; HYPERPHAGIA; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; LEPTIN; MALE; MOLECULAR SEQUENCE DATA; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; RNA PROBES; RNA, MESSENGER; UP-REGULATION; WEIGHT GAIN;

EID: 0031972988     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1998.00170.x     Document Type: Article

References (41)

1. Anand BK, Broeck JR. Hypothalamic control of food intake in rats and cats. Yale J Biol Med 1951; 24: 123-140.
2. Bray GA. Mechanism for development of genetic, hypothalamic and dietary obesity. In: Bray GA, Ryan DH, eds. Molecular and Genetic Aspects of Obesity. Baton Rouge, LA: Louisiana State University Press, 1996; 5: 2 66.
3. Kalra SP. Appetite and body weight regulation. Is it all in the brain? Neuron 1997; 19: 227 230.
4. Hetherington AW, Ranson SW. Experimental hypothalamic-hypophyseal obesity in rats. Proc Soc Exp Biol Med 1939; 41: 465-566.
5. King BM, Frohman LA. Hypothalamic obesity: comparison of radiofrequency and electrolytic lesions in male and female rats. Brain Res Bull 1986; 17: 409-418.
6. Perisic M, Cuenod M. Synaptic transmission depressed by colchicine blockade of axoplasmic flow. Science 1972; 1975: 1140-1142.
7. Mundy WR, Tilson HA. Neurotoxic effects of colchicine. Neurotoxicology 1990; 11: 539-547.
8. Avrith D, Mogenson GJ. Reversible hyperphagia and obesity following intracerebral microinjection of colchicine into the ventromedial hypothalamus of the rat. Brain Res 1978; 153: 99 107.
9. Dube MG, Xu B, Kalra SP, Kalra PS. Neurotoxin-induced transient hyperphagia is negatively correlated with hypothalamic NPY (abstract). Ann Mtg Soc Neurosci 1996; 22: 466.
10. Kalra PS, Dube MG, Kalra SP. Increased neuropeptide Y (NPY) -receptor sensitivity may underlie hyperphagia and obesity: a novel mechanism (abstract). Obesity Research 1996; 4 (suppl 1): 65.
11. Kalra PS, Dube MG, Xu B, Kalra SP. Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain. Reg Peptides 1997; in press.
12. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
13. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winter D, Boone T, Collin F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
14. Campfield LA, Smith FJ, Guisex Y, Devos R, Burn P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural network. Science 1995; 269: 546-549.
15. Caro JF, Sinha MK, Kolaczywski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-1462.
16. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984; 115: 427-429.
17. Kalra SP, Kalra PS. Is neuropeptide Y a naturally-occurring appetite transducer? Curr Opin Endocr Diab 1996; 3: 157-163.
18. Kalra SP, Dube MG, Sahu A, Phelps C, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991; 88: 10931-10935.
19. Dube MG, Sahu A, Phelps CP, Kalra PS, Kalra SP. Neuropeptide Y concentrations decreased in the paraventricular nucleus (PVN) of rats exhibiting excessive body weight gain produced by ventromedial hypothalamic (VMH) lesions (abstract). Ann Mtg Soc Neurosci 1992; 18: 937.
20. Dube MG, Kalra PS, Crowley WR, Kalra SP. Evidence of a physiological role of neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res 1995; 690: 275-278.
21. Kalra SP, Sahu A, Dube MG, Bonavera J, Kalra PS. Neuropeptide Y and its neural connections in the etiology of obesity and associated neuroendocrine and behavioral disorders. In: Bray GA, Ryan DH, eds. Molecular and Genetic Aspects of Obesity. Baton Rouge, LA: Louisiana State University Press, 1996; 219-232.
22. Kalra SP, Dube MG, Fournier A, Kalra PS. Structure-function analysis of stimulation of food intake by neuropeptide Y. Effects of receptor agonists. Phys Behav 1991; 50: 5-9.
23. Gerald C, Walker MW, Criscione L, Gustafson EL, Batz-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL et al. A receptor subtype involved in neuropeptide Y-induced food intake. Nature 1996; 382: 168-171.
24. O'Shea D, Morgan GA, Meeran K, Edwards CMB, Turton MD, Chois J, Heath MM, Gunn I, Taylor GM, Howard JK et al. Neuropeptide Y-induced feeding is mediated by a novel receptor. Endocrinology 1997; 138: 192-202.
25. Daniels AJ, Mathews JE, Sleptis R, Jansen M, Viveros OH, Tadapalli A, Harrington W, Hewer D, Landavazo A, Leban JJ et al. High affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA 1995; 92: 9067-90671.
26. Kanatani A, Ishihara A, Asahi S, Tanaka T, Osaki S, Ihara M. Potent neuropeptide Y Y1 receptor antagonist. 1229U91: blockade of neuropeptide Y-induced physiological food intake. Endocrinology 1996; 137: 3177-3182.
27. Stanley BG, Chin AS, Leibowitz SF. Feeding and drinking elicited by injection of neuropeptide Y. Evidence for hypothalamic site (s) of action. Brain Res Bull 1985; 14: 521-524.
28. Weinberg DH, Sirinathsinghji DJ, Tan CP, Shiao LL, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne ML, Cascieri MA et al. Cloning and expression of a novel neuropeptide Y receptor, J Biol Chem 1996; 271: 16435-16438.
29. Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J et al. Identification of a novel hypothalami neuropeptide Y receptor associated with feeding behavior. J Biol Chem 1996; 271: 26315-26319.
30. Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Kazaki T, Tamoki M, Hayashi M, Yoshimasa Y et al. Pathophysiological significance of the obese gene product, Leptin. in ventromedial hypothalamus (VMH)-lesioned rats: evidence of loss of its satiety effects in VMH-lesioned rats. Endocrinology 1997; 138: 947-953.
31. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997; 138: 839-842.
32. Jacob RJ, Dziura J, Medwick MB, Leone P, Caprio S, During M, Shulen GI, Sherwin RS. The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 1997; 46: 150-152.
33. Mercer JG, Haggard N, William LM, Lawrence CB, Hannah LT. Morgan PJ, Trayhurn P. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendoerinol 1996; 8: 733-735.
34. Stephens TW, Basincki M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffman J, Hsiung HM. Kriauciunas A et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1996; 377: 530-532.
35. Satoh N, Ogawa Y, Katsuura G, Hyase M, Tsuiji T, Iwagawa K, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. The arcuate nucleus as a primary target of satiety effect of leptin in rats. Neurosci Lett 1997; 224: 149-152.
36. Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Martin D, Kalra SP. Anorectic effects of the cytokine. ciliary neurotropic factor (CNTF). are mediated by hypothalamic neuropeptide Y (NPY): Comparison with leptin. Endocrinology 1997; in press.
37. Saladin R, DeVos P, Guerro-Millo M, Leturgue A, Girad J, Staels B, Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995; 377: 527-529.
38. Sclafani A, Kirchgessner A. The role of the medial hypothalamus in the control of food intake: an update. In: Ritter RC, Ritter S, Barnes CD. eds. Feeding Behavior: Neural and Humoral Control. New York: Academic Press, 1986: 27-66.
39. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press, 1986.
40. Kalra PS, Kalra SP. In vivo and in vitro models for evaluating the effects of Interleukin 1 on hypothalamic-pituitary-gonadal axis. Methods Neurosci 1993; 16: 248-268.
41. Larhammar D, Blomquist AG, Yee F, Jazin Em Yoo H, Wahlestedt C. Cloning and functional expression of a human neuropeptide Y peptide YY receptor of the Y1 types. J Biol Chem 1992; 267: 10935 10938.